Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT) in South Africa. He is a Full Member of the UCT Institute of Infectious Disease & Molecular Medicine (IDM), a Tier 1 South Africa Research Chair in Drug Discovery, founding Director of the Medical Research Council (MRC) Drug Discovery and Development Research Unit at UCT and the Founder and Director of the UCT Drug Discovery and Development Centre (H3D).
Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK (1989-1992). This was followed by postdoctoral stints at the University of Liverpool in the UK (1992-94) and at the Scripps Research Institute in the USA (1994-96). He was a Sandler Sabbatical Fellow at the University of California San Francisco (2002), a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine (2008) and a Visiting Professor at Pfizer in the UK (2008).